Prevalence of antibody to hepatitis C virus in acute non-A, non-B hepatitis in patients from different epidemiological categories.
The prevalence of antibodies to hepatitis C virus (HCV) was determined in 65 patients with acute non-A, non-B hepatitis (NANBH). The results suggest that HCV is the most common causative agent in posttransfusion NANBH and in drug-related hepatitis. Detection of HCV antibodies does not appear to be a particularly useful diagnostic criterion due to the kinetics of the immune response in the course of the disease.
Rodríguez
M
M
Hospital Covadonga, Oviedo, Spain.
Riestra
S
S
San Román
F
F
Navascues
C A
CA
Suárez
A
A
Pérez
R
R
Lombraña
J L
JL
Rodrigo
L
L
D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology; D006801:Humans; D015819:Substance Abuse, Intravenous / Q000150:complications; D065227:Transfusion Reaction
D006508:Hepatitis Antibodies